- Associated Press - Thursday, August 7, 2014

ALBANY, N.Y. (AP) - New York is getting $1.7 million as its share of a $35 million multi-state settlement with pharmaceutical giant Pfizer over the marketing of the drug Rapamune.

New York is among 42 states that sued Pfizer subsidiary Wyeth for improper marketing and promotion of the drug.

New York Attorney General Eric Schneiderman says Wyeth promoted the immunosuppressive drug for uses that were not FDA approved.

The drug is approved to prevent the body’s immune system from rejecting a transplanted kidney. Schneiderman says Wyeth improperly promoted Rapamune for liver, heart and lung transplants.

The company didn’t admit any wrongdoing or liability in the settlement.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide